Thermo Fisher Scientific Expands Orbitrap Innovation Across Research, Biopharma and Applied Testing at ASMS 2026

About this update from Thermo Fisher Scientific Inc

New Orbitrap platforms, AI-enabled software and integrated workflows deliver deeper insight, more confident development decisions and stronger results across complex scientific markets WALTHAM, Mass., June 01, 2026--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today expanded its suite of Thermo Scientific™ Orbitrap™ mass spectrometry platforms, AI-enabled software and integrated workflows at the American Society for Mass Spectrometry (ASMS) Conference. Across research, biopharma and applied testing, scientists face increasingly complex samples, expanding data sets and greater pressure to deliver confident answers faster. Thermo Fisher helps solve that challenge by bringing its flagship Orbitrap technology to more scientific decision points. The company’s expanded portfolio combines the depth of high-resolution accurate-mass technology with end-to-end solutions, enabling laboratories to advance discoveries, accelerate the development of new medicines and ensure more confident testing for food, air and water. "Orbitrap technology has long set the standard for breakthrough discovery, and customers now want that same confidence across applied scientific markets," said Ronald Tabaksblat, president, chromatography and mass spectrometry, Thermo Fisher Scientific. "At ASMS 2026, we are showcasing how Thermo Fisher is scaling Orbitrap innovation through connected platforms, software and workflows that support advanced research, drug development and applied testing with decision-ready results." Clearer Disease Insights in Research The new Thermo Scientific™ Orbitrap™ Tribrid™ Apex Mass Spectrometer (MS) gives researchers a more powerful way to study challenging samples on a single platform. As Thermo Fisher’s most versatile and highest-performing Orbitrap Tribrid, the Orbitrap Tribrid Apex MS brings multiple capabilities together in one system, including three mass analyzers, a new infrared laser option for alternative fragmentation and Thermo Scientific™ Direct Mass Technology™ Mode. Together, these features help researchers get clearer answers from complex biology earlier in the discovery process. Thermo Fisher also expanded its software capabilities across proteomics, spectral analysis and advanced protein characterization: Greater Confidence in Biopharma and Pharma Drug Development Thermo Fisher unveil...

View stock analysis, news, and events for Thermo Fisher Scientific Inc